Related references
Note: Only part of the references are listed.89Zr-Labeled Anti-PD-L1 Antibody PET Monitors Gemcitabine Therapy-Induced Modulation of Tumor PD-L1 Expression
Kyung-Ho Jung et al.
JOURNAL OF NUCLEAR MEDICINE (2021)
Nanobodies in cancer
Elisha R. Verhaar et al.
SEMINARS IN IMMUNOLOGY (2021)
PET Imaging of Tumor PD-L1 Expression with a Highly Specific Nonblocking Single-Domain Antibody
Gaochao Lv et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
Size and affinity kinetics of nanobodies influence targeting and penetration of solid tumours
Pieterjan Debie et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Improved Detection of Molecular Markers of Atherosclerotic Plaques Using Sub-Millimeter PET Imaging
Jessica Bridoux et al.
MOLECULES (2020)
Radiopharmaceutical therapy in cancer: clinical advances and challenges
George Sgouros et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Nanobody-based therapeutics against colorectal cancer: Precision therapies based on the personal mutanome profile and tumor neoantigens
Azita Moradi et al.
PHARMACOLOGICAL RESEARCH (2020)
VCAM-1 Target in Non-Invasive Imaging for the Detection of Atherosclerotic Plaques
Kathleen Thayse et al.
BIOLOGY-BASEL (2020)
Radiometal-labeled anti-VCAM-1 nanobodies as molecular tracers for atherosclerosis - impact of radiochemistry on pharmacokinetics
Gezim Bala et al.
BIOLOGICAL CHEMISTRY (2019)
The role of carbonic anhydrase IX in cancer development: links to hypoxia, acidosis, and beyond
Silvia Pastorekova et al.
CANCER AND METASTASIS REVIEWS (2019)
Remodeling of the Tumor Microenvironment by a Chemokine/Anti-PD-L1 Nanobody Fusion Protein
Tao Fang et al.
MOLECULAR PHARMACEUTICS (2019)
Monitoring the Response of PD-L1 Expression to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Nonsmall-Cell Lung Cancer Xenografts by Immuno-PET Imaging
Dan Li et al.
MOLECULAR PHARMACEUTICS (2019)
Nanobody approval gives domain antibodies a boost
Chris Morrison
NATURE REVIEWS DRUG DISCOVERY (2019)
Nanobody-Facilitated Multiparametric PET/MRI Phenotyping of Atherosclerosis
Max L. Senders et al.
JACC-CARDIOVASCULAR IMAGING (2019)
Pseudomonas Exotoxin Immunotoxins and Anti-Tumor Immunity: From Observations at the Patient's Bedside to Evaluation in Preclinical Models
Yasmin Leshem et al.
TOXINS (2019)
Targeting mannose receptor expression on macrophages in atherosclerotic plaques of apolipoprotein E-knockout mice using 68Ga-NOTA-anti-MMR nanobody: non-invasive imaging of atherosclerotic plaques
Zohreh Varasteh et al.
EJNMMI RESEARCH (2019)
The pharmacology and therapeutic applications of monoclonal antibodies
Maria Sofia Castelli et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2019)
Evaluation of [Tc-99m]Radiolabeled Macrophage Mannose Receptor-Specific Nanobodies for Targeting of Atherosclerotic Lesions in Mice
Gezim Bala et al.
MOLECULAR IMAGING AND BIOLOGY (2018)
Emerging Roles of Vascular Cell Adhesion Molecule-1 (VCAM-1) in Immunological Disorders and Cancer
Deok-Hoon Kong et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Site-specific PEGylation of an anti-CEA/CD3 bispecific antibody improves its antitumor efficacy
Haitao Pan et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
Immuno-PET Imaging of 89Zr Labeled Anti-PD-L1 Domain Antibody
Dan Li et al.
MOLECULAR PHARMACEUTICS (2018)
Evaluation of an Anti-HER2 Nanobody Labeled with 225AC for Targeted alpha-Particle Therapy of Cancer
Marek Pruszynski et al.
MOLECULAR PHARMACEUTICS (2018)
A peptide tag-specific nanobody enables high-quality labeling for dSTORM imaging
David Virant et al.
NATURE COMMUNICATIONS (2018)
Single- and two-photon imaging of human micrometastases and disseminated tumour cells with conjugates of nanobodies and quantum dots
Fernanda Ramos-Gomes et al.
SCIENTIFIC REPORTS (2018)
Nanobody-Based Biologics for Modulating Purinergic Signaling in Inflammation and Immunity
Stephan Menzel et al.
FRONTIERS IN PHARMACOLOGY (2018)
Exploiting Nanobodies' Singular Traits
Jessica R. Ingram et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 36 (2018)
Monosodium Glutamate Reduces Ga-68-PSMA-11 Uptake in Salivary Glands and Kidneys in a Preclinical Prostate Cancer Model
Etienne Rousseau et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Anti-Multiple Myeloma Activity of Nanobody-Based Anti-CD38 Chimeric Antigen Receptor T Cells
Na An et al.
MOLECULAR PHARMACEUTICS (2018)
A novel multifunctional anti-CEA-IL 15 molecule displays potent antitumor activities
Yue Liu et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2018)
1140PDPhase I study of KN035, a novel fusion Anti-PD-L1 antibody administered subcutaneously in patients with advanced solid tumors in the USA
K P Papadopoulos et al.
ANNALS OF ONCOLOGY (2018)
Nanobody-Fc constructs targeting chemokine receptor CXCR4 potently inhibit signaling and CXCR4-mediated HIV-entry and induce antibody effector functions
Vladimir Bobkov et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Nanobody immunostaining for correlated light and electron microscopy with preservation of ultrastructure
Tao Fang et al.
NATURE METHODS (2018)
99mTc-anti-epidermal growth factor receptor nanobody for tumor imaging
Majid Piramoon et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2017)
Molecular Imaging with Kupffer Cell-Targeting Nanobodies for Diagnosis and Prognosis in Mouse Models of Liver Pathogenesis
Fang Zheng et al.
MOLECULAR IMAGING AND BIOLOGY (2017)
Humanized CD7 nanobody-based immunotoxins exhibit promising anti-T-cell acute lymphoblastic leukemia potential
Yuan Yu et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
Human Epidermal Growth Factor Receptor 3-Specific Tumor Uptake and Biodistribution of 89Zr-MSB0010853 Visualized by Real-Time and Noninvasive PET Imaging
Frank J. Warnders et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics
Peter Bannas et al.
FRONTIERS IN IMMUNOLOGY (2017)
Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy
Michael A. Cannarile et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
Structural basis of a novel PD-L1 nanobody for immune checkpoint blockade
Fei Zhang et al.
CELL DISCOVERY (2017)
131I-labeled Anti-HER2 Camelid sdAb as a Theranostic Tool in Cancer Treatment
Matthias D'Huyvetter et al.
CLINICAL CANCER RESEARCH (2017)
Fusion of gelonin and anti-insulin-like growth factor-1 receptor (IGF-1R) affibody for enhanced brain cancer therapy
Songhee Ham et al.
ARCHIVES OF PHARMACAL RESEARCH (2017)
Targeted Radionuclide Therapy: An Evolution Toward Precision Cancer Treatment
Hossein Jadvar
AMERICAN JOURNAL OF ROENTGENOLOGY (2017)
Phase I Study of Ga-68-HER2-Nanobody for PET/CT Assessment of HER2 Expression in Breast Carcinoma
Marleen Keyaerts et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Hypoxia-Targeting Fluorescent Nanobodies for Optical Molecular Imaging of Pre-Invasive Breast Cancer
Aram S. A. van Brussel et al.
MOLECULAR IMAGING AND BIOLOGY (2016)
Single domain antibody-based bispecific antibody induces potent specific anti-tumor activity
Jing Li et al.
CANCER BIOLOGY & THERAPY (2016)
Targeted alpha therapy using short-lived alpha-particles and the promise of nanobodies as targeting vehicle
Yana Dekempeneer et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2016)
Relevance of radiobiological concepts in radionuclide therapy of cancer
Chandan Kumar et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2016)
EGFR targeted nanobody-photosensitizer conjugates for photodynamic therapy in a pre-clinical model of head and neck cancer
Pieter B. A. A. van Driel et al.
JOURNAL OF CONTROLLED RELEASE (2016)
18F-nanobody for PET imaging of HER2 overexpressing tumors
Catarina Xavier et al.
NUCLEAR MEDICINE AND BIOLOGY (2016)
Novel CD7-specific nanobody-based immunotoxins potently enhanced apoptosis of CD7-positive malignant cells
Jinle Tang et al.
ONCOTARGET (2016)
Targeting of vascular cell adhesion molecule-1 by 18F-labelled nanobodies for PET/CT imaging of inflamed atherosclerotic plaques
Gezim Bala et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2016)
Optical imaging of pre-invasive breast cancer with a combination of VHHs targeting CAIX and HER2 increases contrast and facilitates tumour characterization
Marta M. Kijanka et al.
EJNMMI RESEARCH (2016)
Nanobodies as Versatile Tools to Understand, Diagnose, Visualize and Treat Cancer
Isabel Van Audenhove et al.
EBIOMEDICINE (2016)
Anti-programmed cell death protein-1/ligand-1 therapy in different cancers
B. Homet Moreno et al.
BRITISH JOURNAL OF CANCER (2015)
Monitoring liver macrophages using nanobodies targeting Vsig4: Concanavalin A induced acute hepatitis as paradigm
Fang Zheng et al.
IMMUNOBIOLOGY (2015)
PET Imaging of Macrophage Mannose Receptor-Expressing Macrophages in Tumor Stroma Using 18F-Radiolabeled Camelid Single-Domain Antibody Fragments
Anneleen Blykers et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
Daniel W. Lee et al.
LANCET (2015)
Increasing the potency of neutralizing single-domain antibodies by functionalization with a CD11b/CD18 binding domain
Martin A. Rossotti et al.
MABS (2015)
PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy
Sandip Pravin Patel et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Targeting Tumor-Associated Macrophages with Anti-CSF-1R Antibody Reveals a Strategy for Cancer Therapy
Carola H. Ries et al.
CANCER CELL (2014)
Molecular Imaging with Macrophage CRIg-Targeting Nanobodies for Early and Preclinical Diagnosis in a Mouse Model of Rheumatoid Arthritis
Fang Zheng et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Improved Tumor Targeting of Anti-HER2 Nanobody Through N-Succinimidyl 4-Guanidinomethyl-3-Iodobenzoate Radiolabeling
Marek Pruszynski et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Cancer-related inflammation and treatment effectiveness
Connie I. Diakos et al.
LANCET ONCOLOGY (2014)
Nanobody-photosensitizer conjugates for targeted photodynamic therapy
Raimond Heukers et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2014)
The cellular and molecular origin of tumor-associated macrophages
Ruth A. Franklin et al.
SCIENCE (2014)
Nanobody-based products as research and diagnostic tools
Thomas De Meyer et al.
TRENDS IN BIOTECHNOLOGY (2014)
GPCR-targeting nanobodies: attractive research tools, diagnostics, and therapeutics
Azra Mujic-Delic et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2014)
Targeted Radionuclide Therapy with A 177Lu-labeled Anti-HER2 Nanobody
Matthias D'Huyvetter et al.
THERANOSTICS (2014)
Nanobody: The Magic Bullet for Molecular Imaging?
Rubel Chakravarty et al.
THERANOSTICS (2014)
Intrinsically active nanobody-modified polymeric micelles for tumor-targeted combination therapy
Marina Talelli et al.
BIOMATERIALS (2013)
Rapid optical imaging of human breast tumour xenografts using anti-HER2 VHHs site-directly conjugated to IRDye 800CW for image-guided surgery
Marta Kijanka et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Camelid single-domain antibody-fragment engineering for (pre)clinical in vivo molecular imaging applications: adjusting the bullet to its target
Jens De Vos et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2013)
Nanobody-albumin nanoparticles (NANAPs) for the delivery of a multikinase inhibitor 17864 to EGFR overexpressing tumor cells
Isil Altintas et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Targeting tumors with nanobodies for cancer imaging and therapy
Sabrina Oliveira et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Diphtheria toxin-based targeted toxin therapy for brain tumors
Yan Michael Li et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
Synthesis, Preclinical Validation, Dosimetry, and Toxicity of 68Ga-NOTA-Anti-HER2 Nanobodies for iPET Imaging of HER2 Receptor Expression in Cancer
Catarina Xavier et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Efficient growth inhibition of EGFR over-expressing tumor cells by an anti-EGFR nanobody
Kobra Omidfar et al.
MOLECULAR BIOLOGY REPORTS (2013)
A Highly Specific Gold Nanoprobe for Live-Cell Single-Molecule Imaging
Cecile Leduc et al.
NANO LETTERS (2013)
CSF-1R inhibition alters macrophage polarization and blocks glioma progression
Stephanie M. Pyonteck et al.
NATURE MEDICINE (2013)
Leukocyte Behavior in Atherosclerosis, Myocardial Infarction, and Heart Failure
Filip K. Swirski et al.
SCIENCE (2013)
Inflammation in Atherosclerosis
Peter Libby
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Nanobody-Based Targeting of the Macrophage Mannose Receptor for Effective In Vivo Imaging of Tumor-Associated Macrophages
Kiavash Movahedi et al.
CANCER RESEARCH (2012)
Nanobodies Targeting Mouse/Human VCAM1 for the Nuclear Imaging of Atherosclerotic Lesions
Alexis Broisat et al.
CIRCULATION RESEARCH (2012)
Development of the Nanobody display technology to target lentiviral vectors to antigen-presenting cells
C. Goyvaerts et al.
GENE THERAPY (2012)
Tumor-targeted Nanobullets: Anti-EGFR nanobody-liposomes loaded with anti-IGF-1R kinase inhibitor for cancer treatment
Roy van der Meel et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Nanobodies Targeting the Hepatocyte Growth Factor: Potential New Drugs for Molecular Cancer Therapy
Maria J. W. D. Vosjan et al.
MOLECULAR CANCER THERAPEUTICS (2012)
A simple, versatile method for GFP-based super-resolution microscopy via nanobodies
Jonas Ries et al.
NATURE METHODS (2012)
Specific Cell Targeting with Nanobody Conjugated Branched Gold Nanoparticles for Photothermal Therapy
Bieke Van de Broek et al.
ACS NANO (2011)
Localization, mechanism and reduction of renal retention of technetium-99m labeled epidermal growth factor receptor-specific nanobody in mice
Lea Olive Tchouate Gainkam et al.
CONTRAST MEDIA & MOLECULAR IMAGING (2011)
Immuno-imaging using nanobodies
Ilse Vaneycken et al.
CURRENT OPINION IN BIOTECHNOLOGY (2011)
Downregulation of EGFR by a novel multivalent nanobody-liposome platform
Sabrina Oliveira et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Enhancement of toxin- and virus-neutralizing capacity of single-domain antibody fragments by N-glycosylation
M. M. Harmsen et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2009)
Anti-MUC1 Nanobody Can Redirect T-Body Cytotoxic Effector Function
Seyed Hamid Aghaee Bakhtiari et al.
HYBRIDOMA (2009)
SPECT imaging with 99mTc-labeled EGFR-specific nanobody for in vivo monitoring of EGFR expression
Lieven Huang et al.
MOLECULAR IMAGING AND BIOLOGY (2008)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
Ricin poisoning - A comprehensive review
J Audi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Nanobodies as novel agents for cancer therapy
H Revets et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2005)
A major role for VCAM-1, but not ICAM-1, in early atherosclerosis
MI Cybulsky et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Share Paper
